<code id='AD8EAB2C91'></code><style id='AD8EAB2C91'></style>
    • <acronym id='AD8EAB2C91'></acronym>
      <center id='AD8EAB2C91'><center id='AD8EAB2C91'><tfoot id='AD8EAB2C91'></tfoot></center><abbr id='AD8EAB2C91'><dir id='AD8EAB2C91'><tfoot id='AD8EAB2C91'></tfoot><noframes id='AD8EAB2C91'>

    • <optgroup id='AD8EAB2C91'><strike id='AD8EAB2C91'><sup id='AD8EAB2C91'></sup></strike><code id='AD8EAB2C91'></code></optgroup>
        1. <b id='AD8EAB2C91'><label id='AD8EAB2C91'><select id='AD8EAB2C91'><dt id='AD8EAB2C91'><span id='AD8EAB2C91'></span></dt></select></label></b><u id='AD8EAB2C91'></u>
          <i id='AD8EAB2C91'><strike id='AD8EAB2C91'><tt id='AD8EAB2C91'><pre id='AD8EAB2C91'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:79769
          gantenerumab Alzheimer's disease Roche
          Sebastien Bozon/AFP via Getty Images

          Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases. 

          Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world. 

          advertisement

          The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Allen Institute goes after foundational questions, CEO Costa says
          Allen Institute goes after foundational questions, CEO Costa says

          AllenInstituteCEORuiCostaCourtesyAllenInstituteMappingthebillionsofcellsthatmakeupthebrainisataskmam

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

          EricTokatisco-presidentofinvestmentbankingatCenterviewPartners.CourtesyCenterviewPartnersSANFRANCISC